US FDA approves X4 Pharmaceuticals' therapy for immunodeficiency disease
X4 Pharmaceuticals said on Monday the U.S. FDA has approved its therapy to treat a rare genetic immunodeficiency disease in ...
FDA Approves X4 Pharmaceuticals' Mavorixafor As First Therapy For Rare Immunodeficiency Disorder
FDA approves Xolremdi capsules for WHIM syndrome, boosting neutrophil & lymphocyte counts. First therapy for this rare ...
FiercePharma4d
X4 enters commercial fold with FDA approval of rare disease drug Xolremdi
With the approval of X4 Pharmaceuticals’ first product mavorixafor, there’s a new commercial rare disease player in town. | ...
Researchers identify a cause of immunodeficiency after stroke and heart attack
Every year, between 250,000 and 300,000 people in Germany suffer from a stroke or heart attack. These patients suffer immune ...
Protein responsible for genetic inflammatory disease identified
A team of researchers led by Dr. Hirotsugu Oda at the University of Cologne's CECAD Cluster of Excellence for Aging Research ...
X4 Pharmaceuticals Gets FDA Approval for Xolremdi Capsules
By Chris Wack X4 Pharmaceuticals said that the Food and Drug Administration approved Xolremdi capsules for use in patients 12 years of age and older ...
Smart Immune treats adult acute leukemia patient at final dose level in Phase I/II ReSET-02 trial
Smart Immune treats adult acute leukemia patient at final dose level in Phase I/II ReSET-02 trialPARIS, France, May 2, 2024 – Smart Immune, a ...
Nature8d
Unravelling the association of partial T-cell immunodeficiency and immune dysregulation
In certain cases, identical mutations can cause severe or partial T-cell immunodeficiency, highlighting the complexity of pathogenesis. For both severe and partial T-cell immunodeficiencies in ...
health.economictimes.indiatimes1d
Apollo Cancer Centres raises awareness around primary immunodeficiency disorders
PIDs represent a group of inherited conditions that compromise the body's immune system, leaving individuals susceptible to ...
X4 Pharma's XOLREMDI Capsules Gets FDA Approval To Treat WHIM Syndrome
X4 Pharmaceuticals (XFOR), focused on rare diseases of the immune system, announced Monday that the U.S. Food and Drug Administration ...
The News Minute3d
Unmasking Primary Immune Disorders: ACC spearheads raising awareness and the battle against PIDs
Apollo Cancer Centres (ACC) advocates raising awareness and addresses the challenges posed by the often-overlooked Primary ...
News Medical22d
Immunodeficiency News and Research
Across the globe, more than 39 million people are living with the Human Immunodeficiency Virus (HIV ... A review article highlights how two X chromosomes in females influence immune system ...